Form 4 holding
10%+ Owner
Edesa Biotech, Inc.
- Security class
- Common share
- Shares / value
- 1,625,133
- Estimated value
- $4,281,575
- Report date
- 10 Jan 2023
- Price
- $2.63
- Ownership
- Held by Lumira Capital II, L.P.
Peter van der Velden
Insider Reports History
- Reporting-owner location
- Markham, Ontario, Canada
- Latest reporting-owner signature
-
/s/ Peter van der Velden
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Peter van der Velden
Form 4 holding
10%+ Owner
Edesa Biotech, Inc.
- Security class
- Common share
- Shares / value
- 150,275
- Estimated value
- $395,915
- Report date
- 10 Jan 2023
- Price
- $2.63
- Ownership
- Held by Lumira Capital II (International), L.P.
Insider Reports Filed by Peter van der Velden
4
EDSA
Edesa Biotech, Inc.
- Report period
- 09 Jan 2023
- Transactions
- 4
- Transaction value
- -$787,716
- Accepted by SEC
- 11 Jan 2023, 14:42
- Role
- 10%+ Owner
- Next action
- Open filing details
3
LAVA Medtech Acquisition Corp.
- Report period
- 26 Oct 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 26 Oct 2021, 17:54
- Role
- Director
- Next action
- Open filing details